Insurance that covers testosterone for FTM transition is widely available: most employer plans, ACA marketplace plans, about half of state Medicaid programs, Medicare, and VA health benefits pay for testosterone prescribed to treat gender dysphoria. What you actually pay, and how much paperwork stands between you and your first vial, depends on the type of plan you carry, the state you live in, and how your prescriber documents the diagnosis.
Which Plans Cover Testosterone for Gender Dysphoria
Plan type is the single biggest factor in whether testosterone is covered and on what terms.
- Employer-sponsored fully insured plans. These are regulated by your state’s insurance department. In roughly half of all states plus the District of Columbia, state law prohibits insurers from blanket-excluding gender-affirming care, so a fully insured employer plan in those states generally cannot deny testosterone solely because it is transition-related.
- Employer-sponsored self-insured plans. Large employers often self-fund, meaning the company pays claims directly. ERISA preempts state insurance mandates for these plans, so a state coverage requirement may not reach your employer’s plan. Coverage comes down to how the employer wrote the benefits.
- ACA marketplace plans. Individual plans bought through HealthCare.gov or a state exchange commonly cover testosterone for gender dysphoria, though cost-sharing and prior authorization rules differ by carrier.
- Medicaid. Roughly 26 states and the District of Columbia explicitly cover gender-affirming care through Medicaid. A growing number of states have restricted or prohibited such coverage, particularly for minors.
- Medicare. In 2014, Medicare removed its blanket exclusion of transition-related surgical care, and Medicare Part D formularies typically list testosterone cypionate as a covered generic.
- VA health benefits. The VA covers hormone therapy for eligible veterans with gender dysphoria, and testosterone injection is on the VA national formulary.
Federal nondiscrimination rules under Section 1557 of the Affordable Care Act prohibit sex discrimination in any health program receiving federal funding.1Office of the Law Revision Counsel. 42 USC 18116 – Nondiscrimination A 2024 HHS rule interpreting that to include gender identity has been blocked in court, and HHS rescinded related guidance in February 2025.2HHS. Rescission of HHS Notice and Guidance on Gender Affirming Care, Civil Rights, and Patient Privacy The practical takeaway: the federal protection explicitly covering gender identity is legally uncertain, so your coverage rights depend more on your plan documents and state law than on federal rulemaking right now.
Read Your Plan Documents First
Before you book an appointment or request a prescription, pull two documents from your insurance portal: the Summary of Benefits and Coverage (SBC) and the Evidence of Coverage (EOC). Search both for language about gender-affirming care, transgender health services, or hormone therapy. A blanket exclusion means an uphill fight; silence or inclusion means a normal prior authorization process.
Then open the formulary, which is the plan’s prescription drug list. It tells you which tier testosterone falls under and what your cost-sharing will be. A UnitedHealthcare Medicare formulary, for example, places generic testosterone cypionate injection at Tier 2 and testosterone enanthate injection at Tier 3, with transdermal gels also at Tier 3.3UnitedHealthcare. Complete Drug List (Formulary) 2025 Lower tiers mean lower co-pays. Brand-name options and gels or patches generally sit at higher tiers with greater out-of-pocket costs.
What Your Prescriber Needs to Document
Nearly every insurer requires a formal gender dysphoria diagnosis before approving testosterone. The diagnosis is documented using an ICD-10 code in the F64 category, such as F64.0, F64.8, or F64.9.4Centers for Medicare & Medicaid Services. Billing and Coding: Sex Reassignment Services for Sexual Identity Dysphoria The specific code can affect whether the claim processes smoothly, so confirm the one your carrier expects.
Beyond the code, insurers typically want documentation of:
- Persistent gender incongruence, often for at least six months.
- Capacity to give informed consent to hormone therapy.
- Reasonably well-managed co-existing mental health conditions.
UnitedHealthcare, for example, requires a DSM-5-TR gender dysphoria diagnosis from a mental health professional plus a prescription from an endocrinologist or a provider experienced in transgender hormone therapy.5UHCprovider.com. Testosterone Replacement or Supplementation Therapy – Commercial Medical Benefit Drug Policy CMS uses similar benchmarks for Medicare.4Centers for Medicare & Medicaid Services. Billing and Coding: Sex Reassignment Services for Sexual Identity Dysphoria
Many clinics now prescribe testosterone under an informed consent model, where the provider explains risks and benefits and you sign documentation confirming you understand, without a separate referral letter from a mental health professional. WPATH’s Standards of Care, Version 8, endorses informed consent for adult hormone therapy.6WPATH. Standards of Care for Transgender and Gender Diverse People, Version 8 FAQs Informed consent speeds up the clinical side, but it does not change what your insurer requires for prior authorization. The prescription is valid either way; the question is whether insurance pays for it.
Getting Prior Authorization Approved
Most insurers require prior authorization before covering testosterone for gender dysphoria. Your prescriber submits the request to the plan’s pharmacy benefit manager with the diagnosis codes and clinical notes.
Timelines are set by federal rules. ERISA employer plans must respond within 72 hours for urgent requests and up to 15 calendar days for non-urgent pre-service requests. Starting in 2026, a CMS rule shortens the window for Medicare Advantage, Medicaid, and CHIP to 72 hours for urgent and 7 calendar days for standard requests.7Centers for Medicare & Medicaid Services. CMS Finalizes Rule to Expand Access to Health Information and Improve the Prior Authorization Process
Approvals are usually valid for up to 12 months before renewal.5UHCprovider.com. Testosterone Replacement or Supplementation Therapy – Commercial Medical Benefit Drug Policy Before filling your first prescription, confirm with the pharmacy that the authorization is on file. Otherwise you may be charged the full retail price at the counter.
Expect ongoing lab monitoring as a condition of continued coverage: blood work at 3 to 6 months after starting, then annually, to check testosterone levels and hematocrit. Most plans cover these labs under your standard lab cost-share. Keep every result and visit note; carriers often ask for them at renewal.
If Your Claim Is Denied
A denial is not final. Federal law requires your insurer to send a written notice explaining why the claim was denied and how to appeal.8Office of the Law Revision Counsel. 29 USC 1133 – Claims Procedure
Internal Appeal
File the internal appeal with your insurer. You generally have 180 days from the denial notice. Work with your prescriber on a letter of medical necessity that answers the specific reason for the denial, documents the gender dysphoria diagnosis and duration of incongruence, and ties the treatment to the WPATH Standards of Care. If the denial cited missing records, send what was missing.
External Review
If the internal appeal is denied, you can request an external review. An Independent Review Organization with no ties to your insurer looks at the case from scratch.9eCFR. 45 CFR 147.136 – Internal Claims and Appeals and External Review Processes The reviewer must decide within 45 days for a standard review or 72 hours for an expedited one. Your insurer pays the cost. If the reviewer reverses the denial, coverage is immediate.
What Testosterone Costs
With Insurance
Generic testosterone cypionate injections on a low formulary tier typically carry a co-pay of about $10 to $40 per month. Gels, patches, and brand-name products on higher tiers may cost more through coinsurance, which is a percentage of the drug price rather than a flat fee. Add specialist visit co-pays, which run roughly $22 to $95 per visit depending on your plan, plus lab co-pays for monitoring.
Without Insurance
Retail prices for generic testosterone cypionate without insurance run roughly $35 to $105 for two 1 mL vials at 200 mg/mL, or $38 to $90 for a single 10 mL multi-dose vial. Prescription discount programs can bring a single 1 mL vial down to as low as $14 to $30. A total testosterone blood test runs about $28 to $52 through online lab services if you are paying cash.
Tax Deductions and Pre-Tax Accounts
Gender-affirming hormone therapy prescribed to treat gender dysphoria qualifies as a deductible medical expense on your federal taxes, a position the IRS adopted after the U.S. Tax Court’s 2010 decision in O’Donnabhain v. Commissioner. You can deduct the portion of total medical expenses, including testosterone, labs, and visits, that exceeds 7.5% of your adjusted gross income.10IRS. Publication 502 (2025), Medical and Dental Expenses The same expenses are eligible for payment from a Health Savings Account or Flexible Spending Account with pre-tax dollars.
A Note on Coverage for Minors
Access for patients under 18 involves additional clinical requirements. Aetna, for example, requires a gender dysphoria diagnosis, at least Tanner stage 2 of puberty, and care from a specialist collaborating with a mental health provider.11Aetna. Testosterone Cypionate Injections – Medical Clinical Policy Bulletins WPATH SOC-8 removed fixed minimum ages but recommends a sustained gender identity experience and multidisciplinary assessment with caregiver involvement.6WPATH. Standards of Care for Transgender and Gender Diverse People, Version 8 FAQs Several states now prohibit gender-affirming medical care for minors, and in those states the state law effectively blocks coverage under both private insurance and Medicaid regardless of what the plan would otherwise pay. Check your state’s current law before assuming a minor’s plan will cover testosterone.